학술논문

GULLIVER-2 IS AN INNOVATIVE, HYBRID, HEPATIC IMPAIRMENT TRIAL OF THE ORAL GALECTIN-3 INHIBITOR GB1211
Document Type
Journal
Source
HEPATOLOGY; OCT 2022, 76 pS1146-pS1147, 2p. Supplement: 1
Subject
Language
English
ISSN
15273350